SCHEMBL29339249

SCHEMBL29339249

COc1cccc2c1C(=O)c1ccc(Cl)cc1C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.55
PIM1 P11309 1/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
MAPT P10636 4/20 0.55
RAB9A P51151 3/20 0.55
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ELANE P08246 6/20 0.54
KDM4E B2RXH2 1/20 0.53
USP2 O75604 1/20 0.53
DUSP3 P51452 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
S100A4 P26447 1/20 0.53
NPC1 O15118 2/20 0.53
TTR P02766 2/20 0.48
APAF1 O14727 1/20 0.48
MITF O75030 1/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL612831 0.84 MAPT (0.74) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL30040053 0.83 ELANE (0.61) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL26187210 0.83 ELANE (0.61) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL11266728 0.83 EGFR (0.56) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL11271335 0.83 EGFR (0.56) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL30610014 0.83 ELANE (0.61) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL29339204 0.83 ELANE (0.58) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL29339918 0.82 EGFR (0.55) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL29338964 0.82 EGFR (0.55) EGFRPIM1MEN1KMT2AMAPT
SCHEMBL3417492 0.82 EGFR (0.76) EGFRPIM1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151672-A1 DIRECTED BIOSYNTHESIS OF MODIFIED ANTHRAQUINONE-FUSED ENEDIYNES AS POTENTIAL CANCER THERAPEUTICS THE JOHNS HOPKINS UNIVERSITY (US) 2024-07-18 WO disclosed